Aesica: Press Releases
Aesica Continues US Expansion with New Appointment
Leading pharmaceutical manufacturer, Aesica, has further enhanced its presence in the US with the appointment of a new business development director for the eastern US, Scott Silaika. ...
Aesica Enhances its Business Development Operation
Leading pharmaceutical manufacturer, Aesica, has appointed Andrew Henderson as business development manager at its head office in Newcastle. Andrew will be based out of the company's head...
Aesica Continues Expansion in the US
Leading pharmaceutical manufacturer Aesica has enhanced its presence in the US through the appointment of a new business development director for the West Coast and the opening of a new site in...
Aesica Granted Licence for Manufacturing Controlled Substances
Aesica Pharmaceuticals, an innovative and service-driven supplier of active pharmaceutical ingredients (APIs), finished dosage forms and custom synthesis solutions, has announced its...
Aesica Signs a New Supply Agreement with Amdipharm
Aesica Pharmaceuticals, an innovative supplier of contract development and manufacturing solutions, has entered into a new multi-year supply agreement with Amdipharm. Under the new contract...
Leading Supplier of APIs and Formulations - Aesica Opens New Offices in China
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, today announced it has opened a representative office in...
Aesica Establishes US Subsidiary to Drive Further Growth in North America
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, today announced it has taken a key step in further expanding...
Leading Supplier of APIs and Formulations - Aesica Opens New Global Headquarters
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, today announced the opening of their new global corporate...
Aesica Appoints Michael Staff Vice President, Sales & Business Development, North America
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, announces the appointment of Michael Staff as Vice President,...
Aesica Acquires Chemical Manufacturing Facility from Merck Sharp & Dohme
Cramlington UK 9th October 2006 - Aesica, a leading supplier of active pharmaceutical ingredients to the global pharmaceutical industry, today announces it has acquired the chemical...
FDA Audit Success
On Tuesday the 13th June 2006, the U.S. Food and Drug Administration (FDA) started an intensive three day Good Manufacturing Practice (GMP) audit on Aesica's Cramlington site. The basis of...
Aesica Attendance at Exhibitions and Trade Events 2006
Aesica has arranged to participate in the following events in 2006: Chemspec, Palexpo, Geneva, 14-15 June 2006 Pabord, Excel, London, 13-14 September 2006 CPhI Europe,...
Aesica is Granted a Certificate of Suitability for Flurbiprofen
Aesica Pharmaceuticals has been granted a Certificate of Suitability for Flurbiprofen by the European Directorate for the Quality of Medicines (EDQM). The certificate, number R0-CEP...
Aesica Achieves British Safety Council Award
Aesica Pharmaceuticals has achieved an International Safety Award for 2005, awarded by the British Safety Council. The award is a tribute to the excellent safety record of the...
Aesica Employee Wins Award
Aesica Pharmaceuticals is delighted to announce that Louise Sixsmith, Materials Management Co-ordinator, was awarded Young Achiever of the Year by NEPIC, The Norh East Process Industry Cluster,...
Aesica wins 1st Prize in the Pharmascience 2005 Preferred Vendor Award
Aesica has won the 1st Prize in the inaugural Pharmascience Preferred Vendor Award. Members of the Pharmascience Executive Committee presented a commemorative plaque to Alan Rankin, Sales...
Aesica Exhibits at Informex 2006
Aesica Pharmaceuticals will be exhibiting at the Informex Trade Show being held at the Orange County Convention Centre, Orlando, Florida from 14th - 17th February...
Aesica Secures Major Alzheimer's Drug Contract
UK-based Aesica Pharmaceuticals today announced that they have signed a multimillion-dollar agreement with US biopharmaceutical company Myriad Pharmaceuticals Inc. The contract, which will...
Twitter